Predictions
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€70.32
06.02.23
06.02.23
-
06.02.24
06.02.24
103.92%
07.02.24
07.02.24
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€70.32
05.02.23
05.02.23
-
05.02.24
05.02.24
32.42%
14.05.23
14.05.23
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€64.90
27.01.23
27.01.23
-
27.01.24
27.01.24
103.93%
28.01.24
28.01.24
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€47.09
03.01.23
03.01.23
-
03.01.24
03.01.24
49.33%
05.02.23
05.02.23
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€43.39
29.12.22
29.12.22
-
29.12.23
29.12.23
206.52%
30.12.23
30.12.23
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€43.58
29.12.22
29.12.22
-
29.12.23
29.12.23
67.92%
06.03.23
06.03.23
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€47.36
21.12.22
21.12.22
€66.00
21.12.23
21.12.23
33.70%
27.01.23
27.01.23
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€41.50
16.10.22
16.10.22
-
16.10.23
16.10.23
5.71%
29.10.22
29.10.22
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€98.00
06.07.22
06.07.22
€120.00
06.08.22
06.08.22
-9.88%
07.08.22
07.08.22
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€95.96
06.07.22
06.07.22
€120.00
06.07.23
06.07.23
-0.52%
30.05.23
30.05.23
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€87.46
05.07.22
05.07.22
€100.00
05.07.23
05.07.23
13.74%
06.07.23
06.07.23
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€94.96
07.06.22
07.06.22
€100.00
07.06.23
07.06.23
1.71%
08.06.23
08.06.23
Could be worthwhile Investment >10% per year
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€102.90
31.05.22
31.05.22
€68.00
31.05.23
31.05.23
-38.37%
09.02.23
09.02.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€75.86
12.04.22
12.04.22
€115.00
12.05.22
12.05.22
11.13%
13.05.22
13.05.22
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€86.20
05.04.22
05.04.22
€100.00
01.09.22
01.09.22
19.37%
31.05.22
31.05.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€81.70
17.03.22
17.03.22
€105.00
17.03.23
17.03.23
-49.58%
23.09.22
23.09.22
Fair valuation
Known brand
Growths faster than the competition
Revenue growth >5% per year expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€108.20
28.01.22
28.01.22
€130.00
28.01.23
28.01.23
-12.24%
07.06.22
07.06.22
Could be worthwhile Investment >10% per year
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€149.30
04.12.21
04.12.21
€105.00
04.12.22
04.12.22
-70.36%
21.09.22
21.09.22
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€160.00
30.11.21
30.11.21
€200.00
31.12.24
31.12.24
-66.25%
07.09.22
07.09.22
Could be worthwhile Investment >10% per year
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€158.50
26.11.21
26.11.21
€190.00
26.11.22
26.11.22
-22.15%
18.12.21
18.12.21
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€155.10
15.11.21
15.11.21
€200.00
15.11.22
15.11.22
5.29%
27.11.21
27.11.21
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€139.70
18.10.21
18.10.21
€111.00
18.10.22
18.10.22
-69.69%
19.10.22
19.10.22
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€123.90
04.10.21
04.10.21
-
04.10.22
04.10.22
-60.45%
05.10.22
05.10.22
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€120.30
06.08.21
06.08.21
-
06.08.22
06.08.22
-32.29%
13.03.22
13.03.22
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€132.40
08.07.21
08.07.21
-
08.07.22
08.07.22
-26.99%
08.07.22
08.07.22
Top 10 in its market
Well known brand
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year